Breaking News Instant updates and real-time market news.

PODD

Insulet

$89.81

1.07 (1.21%)

07:48
07/10/18
07/10
07:48
07/10/18
07:48

Insulet price target raised to $115 from $100 at BMO Capital

BMO Capital analyst Joanne Wuensch raised her price target on Insulet to $115 while also adding the company to her Top Picks list as part of her broader Medical Technology: Mid-year View research note. The analyst notes that the company is "on the right side of a secular trend towards better diabetes management, with a full product pipeline, improved reimbursement, and marching rapidly towards cash flow break-even". Wuensch also kept her Outperform rating on Insulet.

PODD Insulet
$89.81

1.07 (1.21%)

05/03/18
PIPR
05/03/18
NO CHANGE
Target $90
PIPR
Overweight
Insulet price target raised to $90 at Piper Jaffray on management confidence
Piper Jaffray analyst JP Kim raised his price target on Insulet to $90 from $88 and kept his Overweight rating, citing the company's Q1 earnings beat and a conference call showcasing the management "oozing with confidence". Kim further notes that Insulet stands to benefit from the tailwinds in Animas, UNH and Medicare, along with a "flawless" execution by the management. The analyst adds that the tone of the call was even more bullish than the updated increase in guidance would suggest, which could result in another FY18 view upgrade after the release of Q2 results.
06/04/18
PIPR
06/04/18
NO CHANGE
Target $106
PIPR
Overweight
Insulet price target raised to $106 from $90 at Piper Jaffray
Piper Jaffray analyst JP McKim raised his price target for Insulet to $106 after the company announced the approval of Dash. While Dash coming free with the purchase of pods is slight revenue and gross margin headwind, it will greatly improve patient access, more than offsetting these headwinds, McKim tells investors in a research note. He continues to recommend investors own the stock and keeps an Overweight rating on Insulet.
06/26/18
WBLR
06/26/18
NO CHANGE
WBLR
Outperform
DexCom positioned to benefit from trends in CGM, pump tech, says William Blair
After attending the annual American Diabetes Association meeting over the weekend, William Blair analyst Margaret Kaczor said she is more confident that the rate of adoption of CGM and pump technologies is picking up traction, with DexCom (DXCM) and Insulet (PODD) well positioned to benefit from the trend and hit or exceed estimates. Kaczor, who has an Outperform rating on DexCom, said she is aware of the uncertainty that Libre adds to the marketplace, though she is a "firm believer" in the category and the ability for multiple players to win. The long-term potential market remains large, she contends, adding that the company's initial start to 2018 suggests its fundamentals have been generally unaffected by competitive launches. She has an Outperform rating on DexCom shares.
06/26/18
WBLR
06/26/18
NO CHANGE
WBLR
Outperform
Insulet continues to 'fire on all cylinders,' says William Blair
After attending the annual American Diabetes Association meeting over the weekend, William Blair analyst Margaret Kaczor said she is more confident that the rate of adoption of CGM and pump technologies is picking up traction, with Insulet (PODD) and DexCom (DXCM) well positioned to benefit from the trend and hit or exceed estimates. In a research note to investors, Kaczor says Insulet "continues to fire on all cylinders," and she sees multiple catalysts over the next few years to drive top- and bottom-line performance. She believes Insulet is on track to achieve $1B in sales or more, with gross margin of 70%+ and operating margin in the mid-teens or higher by 2021.

TODAY'S FREE FLY STORIES

NFLX

Netflix

09:28
10/17/18
10/17
09:28
10/17/18
09:28
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TPR

Tapestry

$44.48

1.39 (3.23%)

09:27
10/17/18
10/17
09:27
10/17/18
09:27
Upgrade
Tapestry rating change  »

Tapestry upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NFLX

Netflix

$346.40

13.29 (3.99%)

09:26
10/17/18
10/17
09:26
10/17/18
09:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PVTL

Pivotal Software

$19.94

1.44 (7.78%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Hot Stocks
Pivotal Software weakness attributed to lock-up expiration »

Shares of Pivotal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$158.81

5.25 (3.42%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Periodicals
Facebook Watch lands The Real World from MTV, Deadline reports »

Facebook Watch will now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

COOP

Mr. Cooper

$15.22

-0.39 (-2.50%)

09:24
10/17/18
10/17
09:24
10/17/18
09:24
Recommendations
Mr. Cooper analyst commentary  »

Mr. Cooper price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.95

0.07 (1.80%)

, GLNCY

Glencore

$0.00

(0.00%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Diana Shipping reports continuation of time charter contract with Glencore »

Diana Shipping (DSX)…

DSX

Diana Shipping

$3.95

0.07 (1.80%)

GLNCY

Glencore

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEON

Neonode

$2.90

0.355 (13.95%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Neonode regains compliance with Nasdaq minimum bid price requirement »

Neonode received a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.89

0.195 (7.25%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Kadmon announces FDA breakthrough therapy designation granted to KD025 »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$145.02

3.9 (2.76%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

GPN

Global Payments

$119.87

4.42 (3.83%)

09:22
10/17/18
10/17
09:22
10/17/18
09:22
Recommendations
Global Payments analyst commentary  »

Global Payments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

HD

Home Depot

$193.61

2.51 (1.31%)

, LOW

Lowe's

$105.97

1.31 (1.25%)

09:21
10/17/18
10/17
09:21
10/17/18
09:21
Downgrade
Home Depot, Lowe's rating change  »

Home Depot, Lowe's…

HD

Home Depot

$193.61

2.51 (1.31%)

LOW

Lowe's

$105.97

1.31 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

GWW

Grainger

$280.03

-38.35 (-12.05%)

09:20
10/17/18
10/17
09:20
10/17/18
09:20
Recommendations
Grainger analyst commentary  »

Grainger selloff may be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HAIR

Restoration Robotics

$1.79

-0.04 (-2.19%)

09:19
10/17/18
10/17
09:19
10/17/18
09:19
Hot Stocks
Restoration Robotics announces results of ARTAS iX case study at ASDS »

Restoration Robotics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

IBM

IBM

$145.02

3.9 (2.76%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Technical Analysis
Technical Take: IBM hits fresh 52-week low after earnings disappoint »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Options
Overnight activity included 287 trades in SPX and 3 trades in VIX »

287 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.88

0.76 (4.19%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Marvell analyst commentary  »

Marvell management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$33.43

1.84 (5.82%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Boingo Wireless analyst commentary  »

Boingo Wireless price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees FY18 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees Q4 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ODP

Office Depot

$2.85

0.005 (0.18%)

, WPP

WPP

$69.83

0.59 (0.85%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Office Depot expands marketing agency of record with WPP »

Office Depot (ODP) and…

ODP

Office Depot

$2.85

0.005 (0.18%)

WPP

WPP

$69.83

0.59 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRTEA

Qurate Retail

$21.94

0.32 (1.48%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Qurate Retail announces long-term iniatitives »

Qurate Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

CREE

Cree

$37.56

2.53 (7.22%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Cree analyst commentary  »

Cree focus on tightening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGI

Renewable Energy

$29.86

1.31 (4.59%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Renewable Energy analyst commentary  »

Renewable Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

PE

Parsley Energy

$29.70

0.7 (2.41%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Downgrade
Parsley Energy rating change  »

Parsley Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.